SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mohamed Emarh, Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study, Archives of Gynecology and Obstetrics, 2015,

    CrossRef

  2. 2
    Johannes Bitzer, Oskari Heikinheimo, Anita L. Nelson, Joaquin Calaf-Alsina, Ian S. Fraser, Medical Management of Heavy Menstrual Bleeding, Obstetrical & Gynecological Survey, 2015, 70, 2, 115

    CrossRef

  3. 3
    DeShawn Taylor, Shannon Connolly, Sue Ann Ingles, Carey Watson, Penina Segall-Gutierrez, Immediate Post-Abortion Insertion of Intrauterine Contraceptives (IUC) in a Diverse Urban Population, Journal of Immigrant and Minority Health, 2014, 16, 3, 416

    CrossRef

  4. You have free access to this content4
    A Ørbo, AB Vereide, M Arnes, I Pettersen, B Straume, Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial, BJOG: An International Journal of Obstetrics & Gynaecology, 2014, 121, 4
  5. 5
    M. Rezk, A. Masood, R. Dawood, Perimenopausal bleeding: Patterns, pathology, response to progestins and clinical outcome, Journal of Obstetrics & Gynaecology, 2014, 1

    CrossRef

  6. 6
    Sokbom Kang, Coexisting carcinoma in endometrial hyperplasia: does more risk factor mean better discrimination?, Journal of Gynecologic Oncology, 2013, 24, 1, 1

    CrossRef

  7. 7
    Eva Dreisler, Lars Grønlund Poulsen, Sofie Leisby Antonsen, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Irene Lambrinoudaki, Faustino R. Pérez-López, Tommaso Simoncini, Florence Tremollieres, Margaret Rees, Lian G. Ulrich, EMAS clinical guide: Assessment of the endometrium in peri and postmenopausal women, Maturitas, 2013, 75, 2, 181

    CrossRef

  8. 8
    I. D. Gallos, P. Krishan, M. Shehmar, R. Ganesan, J. K. Gupta, Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up, Human Reproduction, 2013, 28, 5, 1231

    CrossRef

  9. 9
    Ashlesha Patel, E. Bimla Schwarz, Cancer and contraception, Contraception, 2012, 86, 3, 191

    CrossRef

  10. 10
    Amy J. Armstrong, William W. Hurd, Sonia Elguero, Nichole M. Barker, Kristine M. Zanotti, Diagnosis and Management of Endometrial Hyperplasia, Journal of Minimally Invasive Gynecology, 2012, 19, 5, 562

    CrossRef

  11. 11
    J. Baker, A. Obermair, V. Gebski, M. Janda, Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature, Gynecologic Oncology, 2012, 125, 1, 263

    CrossRef

  12. 12
    OSKARI HEIKINHEIMO, KRISTINA GEMZELL-DANIELSSON, Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS), Acta Obstetricia et Gynecologica Scandinavica, 2012, 91, 1
  13. 13
    Lisa M. Landrum, Rosemary E. Zuna, Joan L. Walker, Clinical Gynecologic Oncology, 2012,

    CrossRef

  14. 14
    L. S. G. Ulrich, Endometrial cancer, types, prognosis, female hormones and antihormones, Climacteric, 2011, 14, 4, 418

    CrossRef

  15. 15
    Eve Espey, Tony Ogburn, Long-Acting Reversible Contraceptives, Obstetrics & Gynecology, 2011, 117, 3, 705

    CrossRef

  16. 16
    Joyce King, Noncontraceptive Uses of Hormonal Contraception, Journal of Midwifery & Women’s Health, 2011, 56, 6
  17. 17
    A. Köninger, F. Otterbach, R. Kimmig, Endokrine Therapie des Endometriumkarzinoms und seiner Präkanzerosen, Gynäkologische Endokrinologie, 2010, 8, 1, 17

    CrossRef

  18. 18
    Ioannis D. Gallos, Manjeet Shehmar, Shakila Thangaratinam, Thalis K. Papapostolou, Arri Coomarasamy, Janesh K. Gupta, Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis, American Journal of Obstetrics and Gynecology, 2010, 203, 6, 547.e1

    CrossRef